Singapore Advancing Medical Research
The Straits Times website noted that whereas pharmaceutical companies previously undertook their research in complete isolation from academia and from other companies, guarding their research closely in private laboratories, the past 10 or 15 years have seen companies and universities moving towards “open innovation”, a collaborative approach which recognizes that no single party has all the elements necessary to create game-changing medicines for the modern age. This open-innovation business model is a very different way of working from the isolated approach of the past, and it requires a certain kind of environment in which to flourish.
Click here to read the full article.